Envoy Medical
COCH • NASDAQ
Envoy Medical is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Brent T. Lucas, with a market cap of $50.2M.
CEOBrent T. Lucas
Next Earnings
Upcoming earnings announcement for Envoy Medical
Date
Thursday, April 30, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.25
Revenue Estimate
$40.0K
Earnings History
Past 10 earnings reports for Envoy Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$0.26Est: -$0.24 | -8.3% | $75.0KEst: $30.0K | +150.0% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.35Est: -$0.28 | -25.0% | $42.0KEst: $72.0K | -41.7% | 10-Q |
| Jul 31, 2025 | Q2 2025 | -$0.32Est: -$0.29 | -10.3% | $78.0KEst: $63.8K | +22.4% | 10-Q |
| May 1, 2025 | Q1 2025 | -$0.29Est: -$0.34 | +14.7% | $46.0KEst: $78.3K | -41.3% | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.46Est: -$0.31 | -48.4% | $42.0KEst: $77.5K | -45.8% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.37Est: -$0.27 | -37.0% | $56.0KEst: $80.0K | -30.0% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.27Est: -$0.25 | -8.0% | $68.0KEst: $82.5K | -17.6% | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.32Est: -$0.26 | -23.1% | $59.0KEst: $100.0K | -41.0% | 10-Q |
| Apr 2, 2024 | Q4 2023 | $0.08Est: -$0.20 | +140.0% | $95.0KEst: $87.5K | +8.6% | — |
| Nov 17, 2023 | Q3 2023 | $0.13 | — | $80.0K | — | — |